Unlocking New Possibilities: Dual Immune Blockade in Brain Metastases from Rare Tumors

The results of a recent trial undoubtedly contribute a vital element to the overarching management of rare tumors and offer new treatment hopes for patients with brain metastases, thereby paving the way for future research in immunotherapy. See related article by Ahluwalia et al., p. 1928.